Act 74 - Suicide Assessment, Prevention, and Treatment - 2021-2023
Western Behavioral Health employees/staff do not have to pay to view the video or for their continuing education certificate.  
Category
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 1.00 APA
  • 1.00 ASWB
  • 1.00 Attendance
Contraindication of Using Nirmatrelvir-Ritonavir (Paxlovid™) With Clozapine
This training is designed to address mental health care professionals who may not realize that medication is under EUA, making it less likely that clinicians and patients and the population at large are aware of life-threatening drug-drug interactions with medications that are highly dependent on
Category
  • Pharmacy
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 0.50 ACPE Pharmacy
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 Attendance
Less is More: Reducing the Anticholinergic Medication Burden in Patients receiving Antipsychotics
This training is designed to address anticholinergic medications such as benztropine (Cogentin) or trihexyphenidyl (Artane) are often used in psychiatry to mitigate extrapyramidal side effects associated with antipsychotic medications.
Category
  • Pharmacy
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Diagnosing Substance Use Disorders and Initiating Medications for Opioid Use Disorder
Outline and Key Points covered by this training includes:Screening for Substance Use.Diagnosis of Substance Use DisordersMedications for Opioid Use DisorderMethadone InitiationBuprenorphine Initiation
Category
  • Pharmacy
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance
Management of Chronic Opioids in People with Concerning Behaviors
Outline and Key Points covered by this training includes:
Category
  • Pharmacy
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Perioperative Management of Medications for Opioid Use Disorder
Outline and Key Points covered by this training includes:Review opportunities in the preoperative intraoperative and post-operative phases of patient care to improve outcomes.
Category
  • Pharmacy
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance
Prescribing Benzodiazepines and Stimulants in OUD Treatment: The Risks and the Benefits
Outline and Key Points covered by this training includes:Prescribing benzodiazepines to people with opioid use disorderThe most effective ADHD treatment for OUDReview the spectrum of attitudes towards prescribing benzodiazepines and risk-benefit ratio
Category
  • Pharmacy
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance
Opioid Use Disorder (OUD) in the Peripartum Period
Outline and Key Points covered by this training includes:Opioid Use Disorder in PregnancyInfant OutcomesResources for Clinicians
Category
  • Pharmacy
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance
Managing Opioid Overdose in the Synthetic Era
Outline and Key Points covered by this training includes:New and Emerging OpioidsManaging Opioid OverdoseNaloxone UseNaloxone-Resistant Overdose
Category
  • Pharmacy
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Attendance
Addressing Addiction in Advanced Illness
Outline and Key Points covered by this training includes:
Category
  • Pharmacy
  • Psychiatry & Psychology
Format
  • Self-study / Enduring
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance

Pages